PRESS RELEASE published on 04/03/2025 at 18:00, 11 months 23 days ago INFORMATION MENSUELLE RELATIVE AUX DROITS DE VOTE Communiqué de presse sur les droits de vote et la présentation de l'entreprise Roche Bobois SA. Informations financières et contacts pour les investisseurs et la presse Chiffre D'affaires Droits De Vote Roche Bobois SA Relation Investisseurs French Art De Vivre
BRIEF published on 03/31/2025 at 18:05, 11 months 26 days ago Roche Bobois: Repurchase of Own Shares Euronext Share Buyback Financial Strategy Roche Bobois Action Program
BRIEF published on 03/31/2025 at 18:05, 11 months 26 days ago Roche Bobois : Rachat d'Actions Propres Rachat D'actions Euronext Stratégie Financière Roche Bobois Programme D'actions
PRESS RELEASE published on 03/31/2025 at 18:00, 11 months 26 days ago RACHAT D'ACTIONS PROPRES Roche Bobois SA annonce les résultats de son programme de rachat d'actions propres du 24 au 28 mars 2025 Rachat D'actions Transactions Finance Programme Roche Bobois SA
BRIEF published on 03/26/2025 at 18:20, 1 year ago Roche Bobois : Résultats 2024 en ligne avec les prévisions Résultats Financiers Dividende Trésorerie EBITDA 2024 Croissance 2025
BRIEF published on 03/26/2025 at 18:20, 1 year ago Roche Bobois: 2024 results in line with forecasts Financial Results Treasury Dividend EBITDA 2024 Growth 2025
PRESS RELEASE published on 03/26/2025 at 18:15, 1 year ago 2024 RESULTS IN LINE WITH EXPECTATIONS - PROPOSED DIVIDEND OF 1.25 EUR PER SHARE Roche Bobois SA announces 2024 results in line with expectations, proposes dividend of 1.25€ per share. Retail sales on the rise. Company to focus on growth and profitability in 2025 Revenue Growth Dividend Roche Bobois 2024 Results EBITDA Rebound
PRESS RELEASE published on 03/26/2025 at 18:15, 1 year ago RÉSULTATS 2024 CONFORMES AUX ANNONCES - PROPOSITION D'UN DIVIDENDE DE 1,25 EUR PAR ACTION Roche Bobois SA publie des résultats conformes aux annonces pour l'exercice 2024. Dividende proposé de 1,25 EUR par action. Croissance prévue en chiffre d'affaires et EBITDA pour 2025 Chiffre D'affaires EBITDA Résultats Annuels Dividende Roche Bobois SA
BRIEF published on 03/24/2025 at 18:05, 1 year ago Share buyback by Roche Bobois Euronext Share Buyback Stock Market Roche Bobois Authorized Program
BRIEF published on 03/24/2025 at 18:05, 1 year ago Rachat d'actions propres par Roche Bobois Rachat D'actions Euronext Roche Bobois Programme Autorisé Marché Actions
Published on 03/26/2026 at 23:00, 9 minutes ago FutureGen Industries Announces Closing of Debt Settlement
Published on 03/26/2026 at 22:05, 1 hour 4 minutes ago BlackBerry to Announce Fourth Quarter and Fiscal Year 2026 Results on April 9, 2026
Published on 03/26/2026 at 22:00, 1 hour 9 minutes ago Clean Air Metals Receives Provincial Funding and Provides Update on the Thunder Bay North Project
Published on 03/26/2026 at 22:00, 1 hour 9 minutes ago Green Bridge Metals Reports Visible Copper Sulfide Mineralization in Initial 2026 Titac Drilling, Duluth Complex Minnesota
Published on 03/26/2026 at 21:00, 2 hours 9 minutes ago Worksport Reports Record FY 2025 Results, Issues $35M–$42M 2026 Revenue Guidance; Targets Initial Cash Flow Positivity
Published on 03/26/2026 at 20:48, 2 hours 21 minutes ago Dermapharm Holding SE repurchases 4,299,190 shares under its public share buyback offer
Published on 03/26/2026 at 19:20, 3 hours 49 minutes ago Critical Path Institute Launches 'One to Millions' to Reshape the Future of Individualized Medicine at Global Scale
Published on 03/26/2026 at 19:09, 4 hours ago 2CRSi SA: Résultats 1er Semestre 2025/26 : Chiffre d'Affaires 204,7 M€ (x9,8) EBITDA de 9,6 M€ (x4,6)
Published on 03/26/2026 at 19:09, 4 hours ago 2CRSi SA: First Half 2025/26 Results: Revenue of €204.7 million (x9.8) EBITDA of €9.6 million (x4.6)
Published on 03/26/2026 at 18:17, 4 hours 52 minutes ago Eiffage se renforce au capital de Getlink et porte sa participation à 29,40 % du capital
Published on 03/26/2026 at 18:17, 4 hours 52 minutes ago Eiffage strengthens its position in Getlink capital
Published on 03/26/2026 at 18:00, 5 hours 9 minutes ago Arrêté des comptes au 31 décembre 2025 et perspectives 2026
Published on 03/26/2026 at 18:00, 5 hours 9 minutes ago LABORATOIRES EUROMEDIS - Fin du contrat de liquidité
